Geovax Labs Inc (GOVX)
2.96
+0.23
(+8.42%)
USD |
NASDAQ |
Sep 20, 16:00
2.99
+0.03
(+1.01%)
After-Hours: 20:00
Geovax Labs Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | 35.35M |
| September 30, 2022 | 35.35M |
| June 30, 2022 | 27.96M |
| March 31, 2022 | 9.434M |
| December 31, 2021 | 12.78M |
| September 30, 2021 | 12.78M |
| June 30, 2021 | 23.71M |
| March 31, 2021 | 24.79M |
| December 31, 2020 | 12.51M |
| September 30, 2020 | 12.51M |
| June 30, 2020 | 2.048M |
| March 31, 2020 | 1.489M |
| December 31, 2019 | 1.430M |
| September 30, 2019 | 1.682M |
| June 30, 2019 | 1.585M |
| March 31, 2019 | 1.088M |
| December 31, 2018 | 1.49M |
| September 30, 2018 | 1.657M |
| June 30, 2018 | 1.057M |
| March 31, 2018 | 2.142M |
| December 31, 2017 | 1.552M |
| September 30, 2017 | 1.446M |
| June 30, 2017 | 2.145M |
| March 31, 2017 | 1.151M |
| December 31, 2016 | 1.340M |
| Date | Value |
|---|---|
| September 30, 2016 | 1.028M |
| June 30, 2016 | 0.3292M |
| March 31, 2016 | 0.2382M |
| December 31, 2015 | 2.680M |
| September 30, 2015 | 3.553M |
| June 30, 2015 | 3.553M |
| March 31, 2015 | 3.553M |
| December 31, 2014 | 0.8734M |
| September 30, 2014 | 1.616M |
| June 30, 2014 | 1.616M |
| March 31, 2014 | 2.199M |
| December 31, 2013 | 3.259M |
| September 30, 2013 | 1.643M |
| June 30, 2013 | 1.643M |
| March 31, 2013 | 1.06M |
| December 31, 2012 | 2.309M |
| September 30, 2012 | 2.714M |
| June 30, 2012 | 2.714M |
| March 31, 2012 | 2.714M |
| December 31, 2011 | 0.4044M |
| September 30, 2011 | 0.2572M |
| June 30, 2011 | 0.3407M |
| March 31, 2011 | 0.3719M |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.2228M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
1.430M
Minimum
Dec 2019
35.35M
Maximum
Sep 2022
15.27M
Average
12.65M
Median
Cash from Financing (TTM) Benchmarks
| Emergent BioSolutions Inc | -48.50M |
| Tonix Pharmaceuticals Holding Corp | 53.80M |
| Abbott Laboratories | -6.359B |
| SIGA Technologies Inc | -43.03M |
| Chimerix Inc | 0.306M |